Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse

Brain Research

Volumn 933, Issue 2, 2002, Pages 130-138

  Johnson, Elizabeth Anne ^a   O'Callaghan, James P ^a   Miller, Diane B ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

D MDMA; Dopamine; Hippocampus; HPA axis; Serotonin; Striatum

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CORTICOSTERONE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID; PLACEBO; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BIOAVAILABILITY; CELLULAR DISTRIBUTION; CIRCULATION; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOSTERONE BLOOD LEVEL; DOPAMINERGIC SYSTEM; FEMALE; GLIOSIS; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; IMPLANTATION; INVOLUTION; MOUSE; MOUSE STRAIN; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPLEEN; THYMUS; TISSUE CULTURE; VALIDATION PROCESS;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BODY TEMPERATURE; CORTICOSTERONE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNE SYSTEM; MICE; MICE, INBRED C57BL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEOSTRIATUM; NEURONS; NEUROTOXINS; ORGAN SIZE; SEROTONIN; STRESS; TYROSINE 3-MONOOXYGENASE;

EID: 0037134207     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02310-7     Document Type: Article

References (37)

1. Differential corticosteroid regulation of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system: Topography and implications
2. Corticosterone: Narrow range required for normal body and thymus weight and ACTH
3. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats
4. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration
5. Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn-superoxide dismutase transgenic mice
6. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: Effect of anitidepressants
7. 3H]Corticosterone binding in the caudate-putamen
8. Oxidative stress: Free radical production in neural degeneration
9. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: Implications for mood disorders
10. Methamphetamine-induced dopaminergic neurotoxicity: Role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts
11. Repeated exposure results in the loss of the neuroprotective properties of restraint-induced hypothermia in the substituted amphetamine model of striatal dopaminergic neurotoxicity
12. Restraint as a stressor in mice: Against the dopaminergic neurotoxicity of D-MDMA, low body weight mitigates restraint-induced hypothermia and consequent neuroprotection
13. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine
14. Differences between rats and mice in MDMA(methylenedioxymethamphetamine) neurotoxicity
15. Protective and damaging effects of stress mediators
16. The neurobiology of stress: From serendipity to clinical relevance
17. Effects of adverse experiences for brain structure and function
18. Glucocorticoids may alter antioxidant enzyme capacity in the brain: Baseline studies
19. Glucocorticoids may alter antioxidant enzyme capacity in the brain: Kainic acid studies
20. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57Bl/6J mouse
21. Neurotoxicity of D-amphetamine in the C57BL/6J and CD-1 mouse: Interactions with stress and the adrenal system
22. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate
23. Quantification of glial fibrillary acidic protein: Comparison of slot-immunobinding assays with a novel sandwich ELISA
24. Measurement of glial fibrillary acidic protein
25. Neurotoxicity, profiles of substituted amphetamines in the C57BL/6J mouse
26. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitroproprionic acid in rats: Implications for neuroprotection studies
27. A mechanism for glucocorticoid toxicity in the hippocampus: Increased neuronal vulnerability to metabolic insults
28. Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging
29. Glucocorticoids, stress and exacerbation of excitotoxic neuron death
30. Stress, glucocorticoids, and damage to the nervous system: The current state of confusion
31. Genetic determinants of susceptibility to excitotoxic cell death: Implications for gene targeting approaches
32. Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background
33. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors
34. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT
35. Measurement of protein using bicinchoninic acid
36. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement
37. The detection of central nervous system tissue on beef carcasses and in comminuted beef